CRISPR/Cas9 technology generated a C to T change (g.118123372C>T) resulting in an arginine to cysteine substitution at amino acid 1034 (p.R1034C). Missense alleles altering p.R1034 have been identified in families affected by congenital glaucoma. (J:338944)